Tuesday, 30 April 2019

FDA declines to approve Nabriva's antibiotic for urinary tract infections

The U.S. Food and Drug Administration on Tuesday declined to approve Nabriva Therapeutics Plc's antibiotic for complicated urinary tract infections (cUTI), even as the nation grapples with the growing problem of antibiotic resistance.


Teens can have tough time searching for sexual health information online

(Reuters Health) - While teens mostly navigate the internet with ease, they may have a tough time finding information on sexual health, a new study suggests.


EPA says popular weed killer glyphosate is not a carcinogen

The U.S. Environmental Protection Agency said on Tuesday that glyphosate, a chemical in many popular weed killers, is not a carcinogen, contradicting recent decisions by U.S. juries that found that it caused cancer in people.


Dental infections in kids tied to heart disease risk in adulthood

(Reuters Health) - Children who develop cavities and gum disease may be more likely to develop risk factors for heart attacks and strokes decades later than kids who have good oral health, a recent study suggests.


FDA permits sale of Philip Morris IQOS tobacco-heating alternative to cigarettes

The U.S. Food and Drug Administration on Tuesday said it would allow Philip Morris to sell a heated tobacco product called IQOS in the United States, a major victory for the international tobacco giant as it looks to sell more alternatives to traditional cigarettes.


Trump, Democratic leaders to meet on drug prices soon: White House

U.S. President Donald Trump will meet with congressional Democratic leaders soon to discuss drug prices, the White House said on Tuesday following infrastructure talks with House Speaker Nancy Pelosi and Senate Democratic leader Chuck Schumer.


FDA permits sale of Philip Morris IQOS tobacco heating device

The U.S. Food and Drug Administration on Tuesday said it would permit Philip Morris to sell its IQOS tobacco heating system in the United States.


Mallinckrodt shares drop after U.S. joins cases over expensive drug

The U.S. Justice Department has joined a pair of whistleblower lawsuits alleging a drugmaker now owned by Mallinckrodt Plc improperly promoted an expensive multiple sclerosis treatment and paid kickbacks to doctors who prescribed the drug.


Dads' smoking linked with fetal heart problems

(Reuters Health) - Unborn babies are at higher risk of heart defects not just when mothers smoke, but when fathers smoke, too, a new study suggests.


Skipping may be easier on the knees than running and burn more calories

(Reuters Health) - Skipping - an exercise many people may not have tried since their school days on the playground - may actually be a great grownup workout because it puts less stress on the knees than running while burning more calories, a recent study suggests.


Novartis's Sandoz strikes deal for biosimilar of Herceptin

Novartis's Sandoz division has struck a deal with Taiwan's EirGenix Inc to market a biosimilar version of Roche's Herceptin that is now in late-stage development to treat some cancer tumors.


Monday, 29 April 2019

U.S. youth suicides up after Netflix show, cause unclear: study

Suicides by young Americans rose by nearly a third in the month following the 2017 debut of popular Netflix television drama series "13 Reasons Why," in which a teenage girl kills herself, a U.S. study showed on Monday.


Atrial fibrillation patients often overestimate risk of stroke, bleeding

(Reuters Health) - Patients with the irregular heart rhythm atrial fibrillation may overestimate both their risk of having a stroke and their risk of bleeding as a side effect of medication prescribed to prevent strokes, a recent study suggests.